188 related articles for article (PubMed ID: 22179829)
1. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
Qin W; Dong P; Ma C; Mitchelson K; Deng T; Zhang L; Sun Y; Feng X; Ding Y; Lu X; He J; Wen H; Cheng J
Oncogene; 2012 Sep; 31(36):4067-75. PubMed ID: 22179829
[TBL] [Abstract][Full Text] [Related]
2. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
4. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
5. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
6. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
7. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients.
Zhang W; Wang J; Liu SJ; Hua W; Xin XY
Acta Obstet Gynecol Scand; 2009; 88(5):521-7. PubMed ID: 19306133
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
[TBL] [Abstract][Full Text] [Related]
11. bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis.
Hsu SH; Hsieh-Li HM; Huang HY; Huang PH; Li H
Cancer Res; 2005 May; 65(10):4041-50. PubMed ID: 15899793
[TBL] [Abstract][Full Text] [Related]
12. MiR-133b Promotes neurite outgrowth by targeting RhoA expression.
Lu XC; Zheng JY; Tang LJ; Huang BS; Li K; Tao Y; Yu W; Zhu RL; Li S; Li LX
Cell Physiol Biochem; 2015; 35(1):246-58. PubMed ID: 25591767
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
14. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
Oneyama C; Ikeda J; Okuzaki D; Suzuki K; Kanou T; Shintani Y; Morii E; Okumura M; Aozasa K; Okada M
Oncogene; 2011 Aug; 30(32):3489-501. PubMed ID: 21383697
[TBL] [Abstract][Full Text] [Related]
17. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42.
Li Y; Zhu X; Xu W; Wang D; Yan J
Biochem Biophys Res Commun; 2013 Feb; 431(3):560-5. PubMed ID: 23337504
[TBL] [Abstract][Full Text] [Related]
18. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
19. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
[TBL] [Abstract][Full Text] [Related]
20. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6.
Zhu X; Li Y; Shen H; Li H; Long L; Hui L; Xu W
FEBS Lett; 2013 Jan; 587(1):73-81. PubMed ID: 23178712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
